DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,200 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,275,344 | +25.4% | 97,845 | +21.3% | 1.46% | +26.3% |
| Q2 2023 | $19,360,800 | +1.5% | 80,670 | +6.6% | 1.16% | -3.5% |
| Q1 2023 | $19,077,412 | +101792.9% | 75,692 | +7.3% | 1.20% | +0.8% |
| Q4 2022 | $18,723 | -99.9% | 70,540 | +4.9% | 1.19% | -4.0% |
| Q3 2022 | $17,373,000 | +7.9% | 67,261 | +5.9% | 1.24% | +11.3% |
| Q2 2022 | $16,097,000 | +69.2% | 63,491 | +95.8% | 1.11% | +84.0% |
| Q1 2022 | $9,513,000 | +45.6% | 32,431 | +63.3% | 0.60% | +45.4% |
| Q4 2021 | $6,535,000 | +796.4% | 19,864 | +729.4% | 0.42% | +715.7% |
| Q3 2021 | $729,000 | +14.6% | 2,395 | +1.0% | 0.05% | +15.9% |
| Q2 2021 | $636,000 | +19.1% | 2,371 | 0.0% | 0.04% | +15.8% |
| Q1 2021 | $534,000 | -0.7% | 2,371 | -2.1% | 0.04% | -9.5% |
| Q4 2020 | $538,000 | -25.0% | 2,421 | -27.3% | 0.04% | -32.3% |
| Q3 2020 | $717,000 | +6.7% | 3,332 | -12.4% | 0.06% | +3.3% |
| Q2 2020 | $672,000 | +14.5% | 3,803 | -10.3% | 0.06% | 0.0% |
| Q1 2020 | $587,000 | -19.3% | 4,238 | -10.5% | 0.06% | 0.0% |
| Q4 2019 | $727,000 | +10.3% | 4,734 | -0.2% | 0.06% | 0.0% |
| Q3 2019 | $659,000 | +0.8% | 4,744 | +3.7% | 0.06% | -7.7% |
| Q2 2019 | $654,000 | -85.1% | 4,573 | -86.2% | 0.06% | -86.0% |
| Q1 2019 | $4,376,000 | +20.9% | 33,143 | -5.6% | 0.46% | +4.5% |
| Q4 2018 | $3,619,000 | -14.5% | 35,097 | -9.9% | 0.44% | -14.1% |
| Q3 2018 | $4,234,000 | +10.0% | 38,970 | -0.1% | 0.52% | +4.0% |
| Q2 2018 | $3,848,000 | -4.0% | 38,998 | -4.7% | 0.50% | -6.2% |
| Q1 2018 | $4,008,000 | -0.9% | 40,933 | -6.0% | 0.53% | +1.9% |
| Q4 2017 | $4,043,000 | +3.9% | 43,559 | -4.0% | 0.52% | -10.7% |
| Q3 2017 | $3,891,000 | +0.9% | 45,358 | -0.8% | 0.58% | -3.6% |
| Q2 2017 | $3,858,000 | -4.7% | 45,713 | -3.5% | 0.60% | -5.5% |
| Q1 2017 | $4,050,000 | +1.4% | 47,353 | -7.8% | 0.64% | -0.2% |
| Q4 2016 | $3,996,000 | – | 51,336 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |